| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1460-9568.1998.00083.X |
| P698 | PubMed publication ID | 9749743 |
| P2093 | author name string | M Le Moal | |
| G Simonnet | |||
| A Larcher | |||
| E Célèrier | |||
| J P Laulin | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 782-785 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time | |
| P478 | volume | 10 |
| Q34625018 | A genetic analysis of opioid-induced hyperalgesia in mice |
| Q36032904 | Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal |
| Q34485532 | Acute pain management for patients receiving maintenance methadone or buprenorphine therapy |
| Q43516601 | Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia |
| Q30426271 | Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration |
| Q63435894 | Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval |
| Q33754272 | Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia |
| Q37736976 | Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease |
| Q73472926 | Chronic morphine exposure and the expression of heme oxygenase type 2 |
| Q35685680 | Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism |
| Q30483034 | Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure |
| Q34624598 | Do opioids induce hyperalgesia? |
| Q48715405 | Dopamine affects the change of pain-related electrical activity induced by morphine dependence |
| Q48936008 | Early antinociception delays edema but does not reduce the magnitude of persistent pain in the formalin test |
| Q46890768 | Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia |
| Q36003831 | Environmentally induced long-term structural changes: cues for functional orientation and vulnerabilities |
| Q30472657 | Episodic Withdrawal Promotes Psychomotor Sensitization to Morphine |
| Q42479990 | Evidence for opiate-activated NMDA processes masking opiate analgesia in rats |
| Q34154391 | Exogenous and endogenous opioid-induced pain hypersensitivity in different rat strains |
| Q77370856 | Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats |
| Q91839665 | In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia |
| Q35152165 | Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance |
| Q35041398 | Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice |
| Q34809169 | Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy |
| Q37247455 | Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer |
| Q41451155 | Neuroplastic alteration of TTX-resistant sodium channel with visceral pain and morphine-induced hyperalgesia |
| Q44333834 | Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats |
| Q35016925 | Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain |
| Q77311566 | Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity |
| Q42670400 | Opiate-induced hypernociception and chemokine receptors |
| Q42171215 | Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache. |
| Q38318330 | Opioid and chemokine receptor crosstalk: a promising target for pain therapy? |
| Q92527205 | Opioid use disorder |
| Q34303611 | Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. |
| Q46647198 | Opioid-induced analgesia and hyperalgesia |
| Q44807834 | Opioid-induced hyperalgesia. Pathophysiology and clinical relevance |
| Q33640173 | Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity |
| Q30820200 | Pain imaging: future applications to integrative clinical and basic neurobiology |
| Q37858847 | Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies |
| Q39520766 | Potentiation of μ-opioid receptor-mediated signaling by ketamine |
| Q28189431 | Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process |
| Q34532729 | Sugar addiction: the state of the science |
| Q44330069 | Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and kappa-opioid receptor implicated |
| Q38542687 | Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations |
| Q49384858 | The dark side of opioids in pain management: basic science explains clinical observation |
| Q36912585 | The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males. |
| Q42266875 | The improved quality of postoperative analgesia after intrathecal morphine does not result in improved recovery and quality of life in the first 6 months after orthopedic surgery: a randomized controlled pilot study |
| Q36781337 | Thermal sensitivity as a measure of spontaneous morphine withdrawal in mice |
| Q35765718 | Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats |
| Q31813611 | Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. |
| Q80972941 | [Remifentanil-based intraoperative anaesthesia and postoperative pain therapy. Is there an optimal treatment strategy?] |
| Q35801850 | μ-Opioid Receptor Gene A118 G Variants and Persistent Pain Symptoms Among Men and Women Experiencing Motor Vehicle Collision |
Search more.